ClinVar Miner

Submissions for variant NM_000260.4(MYO7A):c.2904G>A (p.Glu968=)

dbSNP: rs111033233
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 4
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine RCV000215887 SCV000271248 likely pathogenic Rare genetic deafness 2015-08-20 criteria provided, single submitter clinical testing The c.2904G>A (p.Glu968Glu) variant in MYO7A has not been previously reported in individuals with hearing loss, but has been identified in 1/8202 East Asian chr omosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.o rg). Although this variant has been seen in the general population, its frequenc y is low enough to be consistent with a recessive carrier frequency. This varian t is located at the last base of the exon, which is a highly conserved nucleotid e that is part of the 5' splice region. Computational tools predict that this v ariant is likely to impact splicing. In addition, a pathogenic variant affectin g the same nucleotide position (c.2904G>T, p.Glu968Asp) has been reported in 7 i ndividuals with Usher syndrome, including one homozygote and five compound heter ozygotes (Bharadwaj 2000, Ouyang 2005, Jacobson 2008, Le Quesne Stabej 2012, Buj akowska 2014, LMM unpublished data). In summary, although additional studies, s uch as functional analysis, are required to fully establish its clinical signifi cance, this variant is likely pathogenic.
Invitae RCV002517524 SCV003006802 pathogenic not provided 2023-05-21 criteria provided, single submitter clinical testing This variant disrupts the c.2904G nucleotide in the MYO7A gene. Other variant(s) that disrupt this nucleotide have been determined to be pathogenic (PMID: 10930322, 15660226, 24199935, 25472526, 26969326). This suggests that this nucleotide is clinically significant, and that variants that disrupt this position are likely to be disease-causing. This sequence change affects codon 968 of the MYO7A mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the MYO7A protein. RNA analysis indicates that this variant induces altered splicing and likely results in a shortened protein product. This variant is present in population databases (rs111033233, gnomAD 0.006%). This variant has been observed in individual(s) with clinical features of autosomal recessive MYO7A-related conditions (PMID: 36164746; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 228280). Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Studies have shown that this variant results in skipping of exon 23, but is expected to preserve the integrity of the reading-frame (PMID: 36164746). For these reasons, this variant has been classified as Pathogenic.
Counsyl RCV000984198 SCV001132255 uncertain significance Usher syndrome type 1 2019-01-24 no assertion criteria provided clinical testing
Counsyl RCV000984287 SCV001132437 uncertain significance Autosomal recessive nonsyndromic hearing loss 2 2019-01-24 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.